Results 211 to 220 of about 120,627 (303)

Osteoarthritis: Mechanisms and Therapeutic Advances

MedComm, Volume 6, Issue 8, August 2025.
A schematic illustration of the pathogenesis and emerging therapeutic strategies for OA, including: risk factors and molecular mechanisms of OA, joint changes between healthy and OA conditions, and current emerging therapeutic approaches for OA. Abbreviations: IA: intra‐articular injection; EVs: extracellular vesicles. ABSTRACT Osteoarthritis (OA) is a
Wei Liu, Ning‐Yi Guo, Jian‐Quan Wang, Bing‐Bing Xu   +3 more
wiley   +1 more source

Correction: Sensing of endogenous retroviruses-derived RNA by ZBP1 triggers PANoptosis in DNA damage and contributes to toxic side effects of chemotherapy. [PDF]

Cell Death Dis
Wang F, Li K, Wang W, Jiang H, He J, Cai J, Ren W, Zhao Y, Song Q, He Y, Ma Y, Feng X, Liu Y, Yu J, Jitkaew S, Ma D, Cai Z.   +16 more
europepmc   +1 more source

Potential Retroviruses in Plants: Tat1 Is Related to a Group of Arabidopsis thaliana Ty3/gypsy Retrotransposons That Encode Envelope-Like Proteins [PDF]

, 1998
David A. Wright, Daniel F. Voytas
openalex   +1 more source

Genomic imprinting at a porcine ZNF locus via a canonical imprinting mechanism

Animal Genetics, Volume 56, Issue 4, August 2025.
Abstract Genomic imprinting causes parent‐of‐origin dependent gene expression, primarily driven by a subset of germline differentially methylated regions that function as imprinting control regions at promoter‐associated CpG islands. While these mechanisms have been investigated in depth in mice and humans, our understanding of the molecular basis of ...
Jinsoo Ahn, In‐Sul Hwang, Mi‐Ryung Park, Seongsoo Hwang, In‐Cheol Cho, Kichoon Lee   +5 more
wiley   +1 more source

Microbiome-Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed? [PDF]

Research (Wash D C)
Zhou X, Tian W, Gu S, Rabinovitch M, Nicolls MR, Snyder MP.   +5 more
europepmc   +1 more source

Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV

HIV Medicine, Volume 26, Issue 8, Page 1267-1288, August 2025.
Abstract Introduction Randomized controlled trial evidence suggests that long‐acting injectable (LA‐I) cabotegravir and rilpivirine (CAB+RPV) has similar virological failure (VF) rates to daily oral therapy, but clinical practice evidence is lacking. Integrase inhibitor (INI) resistance may limit future therapy.
Kyle Ring, Alexa Elias, Megan Devonald, Melanie Smuk, Chloe Orkin   +4 more
wiley   +1 more source

Immune and vascular modulation by HERVs: the role of <i>CXCR1</i> and <i>IL18RAP</i> in dengue severity progression. [PDF]

Front Immunol
Ferreira CS, Da Silva AT, Brustolini OJB, Soares BRP, Manuli ER, Ramundo MS, Paranhos-Baccala G, Sabino EC, Vasconcelos ATR.   +8 more
europepmc   +1 more source

Protein sequence comparisons show that the ‘pseudoproteases’ encoded by poxviruses and certain retroviruses belong to the deoxyuridine triphosphatase family

, 1990
Duncan J. McGeoch
openalex   +1 more source

Molecular Structure of a Gypsy Element of Drosophila Subobscura (Gypsyds) Constituting a Degenerate Form of Insect Retroviruses [PDF]

, 1996
T. M. Alberola, Rosa de Llanos
openalex   +1 more source

Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology

CA: A Cancer Journal for Clinicians, Volume 75, Issue 4, Page 282-307, July/August 2025.
Abstract The peripheral T‐cell lymphomas (PTCL) are the only disease for which four histone deacetylase (HDAC) inhibitors have been approved globally as single agents. Although it is not clear why the PTCL exhibit such a vulnerability to these drugs, understanding the biological basis for this activity is essential.
Ariana Sabzevari, Johnson Ung, Jeffrey W. Craig, Kallesh D. Jayappa, Ipsita Pal, David J. Feith, Thomas P. Loughran Jr, Owen A. O’Connor   +7 more
wiley   +1 more source